CarbelimPhycocyanin extraction started.
Initial processing underway to assess yield and purity. Moving toward sustainable bio-based solutions.
sayzardvitrupo (@vitrupo)
의학을 소프트웨어처럼 다루는 ‘프로그래머블 메디슨’ 비전이 소개됐다. 질병 관련 유전자를 찾아내고, 단백질을 설계한 뒤, 건강한 복사본을 삽입해 개인 맞춤 치료를 구현할 수 있다는 내용으로, 정밀의료와 생명공학 AI의 가능성을 강조한다.
https://x.com/vitrupo/status/2043185880115073492
#medicine #biotech #personalizedmedicine #proteinengineering #ai
U3dnMobile Power Ups Biotech Package #3Dpowerups #Biotech #Mobilegames #Browsergames #Powerups #Animations #Cubemap #Scriptcomponent #AssetStore
https://u3dn.com/packages/mobile-power-ups-biotech-package-67070
Brian RepkoThe next (April) #BioTech #Minnesota Networking event in the #TwinCities is set for Mon April 13th (6-8pm) at Lake Monster Brewing (where it all started!)
Substack post is https://substack.com/inbox/post/191818450
And luma event page is at https://luma.com/c86p3t4a
katch wreck#askfedi any useful biomedical angel investor resources or links floating around these parts? our focus is novel biomarkers of epilepsy & neurodegenation #investing #startup #startups #biomedical #neuromedical #medicine #biotech #biomed #neuroscience #epilepsy #neurodegeneration #biomarker
jbz😣 Inside the stealthy startup that pitched brainless human clones
｢ A key inspiration for Schloendorn is a birth defect in which children are born missing most of their cortical hemispheres; he’s shown people medical scans of these kids’ nearly empty skulls as evidence that a body can live without much of a brain ｣
Mark Gadala-Maria (@markgadala)
Loyal의 LOY-002가 FDA로부터 노령견 수명 연장에 대한 '효과 가능성의 합리적 기대' 확인을 받았다고 소개했다. 반려동물 대상의 항노화 치료제라는 점에서 매우 이례적이며, AI와 직접 연관은 없지만 바이오·의료 혁신 측면에서 중요한 신약 규제 진전이다.
Mark Gadala-Maria (@markgadala) on X
The FDA just did something it has never done in its entire history. It greenlit an anti-aging drug. For dogs. Loyal's LOY-002 received FDA confirmation of a "reasonable expectation of effectiveness" for lifespan extension in senior dogs this week. A daily, beef-flavored pill.
Jacob Trefethen (@JacobTref)
OpenAI Foundation이 알츠하이머병의 복잡한 난제를 해결하기 위해 1억 달러 이상을 투입해 질병 매핑, 신약 설계 등 연구를 지원한다고 발표했다. AI를 의학 연구에 적용하는 대형 사회적·과학적 프로젝트로, 의료 AI의 새로운 활용 사례로 주목된다.
Jacob Trefethen (@JacobTref) on X
Alzheimer’s is one of medicine's hardest unsolved problems, and one of the most devastating. At the OpenAI Foundation, we believe AI is well suited to its complexity. We're directing over $100M to scientists mapping the disease, designing drugs, & more. I wrote about it here:
Howard Smith MD, AMRestoring Sperm Production For Infertile Couples. A targeted mRNA treatment restores sperm production in genetically infertile mice and allows them to father healthy offspring. Hope it works for humans. #MedicalResearch #ReproductiveHealth #Biotech #ScienceNews #HealthScience
https://www.instagram.com/p/DW4bJYnGHpz/
https://www.instagram.com/p/DW4bJYnGHpz/
Howard G. Smith MD, AM on Instagram: "Restoring Sperm Production For Infertile Couples A targeted mRNA treatment restores sperm production in genetically infertile mice and allows them to father healthy offspring. This according to molecular biologists at Japan’s Kyoto University. Messenger RNA, injected into the testes of male mice that carry a genetic defect which usually prevents sperm production, remains active for about two days and delivers vital instructions to both sperm-producing cells and support cells. Following this treatment, sperm collected from the mice successfully reverses infertility and produces healthy offspring through in-vitro fertilization. Male factors drive infertility in roughly 40% of the 10% of couples worldwide who struggle to conceive. This is equal to females issues. This mRNA fertility reversal is still in the stages of development, and clinical trials are needed to refine and determine the safety and effectiveness of the technique in humans. Hopefully, therapeutic mRNA might help couples suffering with infertility…… someday soon. References on my website. #MedicalResearch #ReproductiveHealth #Biotech #ScienceNews #HealthScience"
0 likes, 0 comments - drhowardsmithreports on April 8, 2026: "Restoring Sperm Production For Infertile Couples A targeted mRNA treatment restores sperm production in genetically infertile mice and allows them to father healthy offspring. This according to molecular biologists at Japan’s Kyoto University. Messenger RNA, injected into the testes of male mice that carry a genetic defect which usually prevents sperm production, remains active for about two days and delivers vital instructions to both sperm-producing cells and support cells. Following this treatment, sperm collected from the mice successfully reverses infertility and produces healthy offspring through in-vitro fertilization. Male factors drive infertility in roughly 40% of the 10% of couples worldwide who struggle to conceive. This is equal to females issues. This mRNA fertility reversal is still in the stages of development, and clinical trials are needed to refine and determine the safety and effectiveness of the technique in humans. Hopefully, therapeutic mRNA might help couples suffering with infertility…… someday soon. References on my website. #MedicalResearch #ReproductiveHealth #Biotech #ScienceNews #HealthScience".
AI Blood Test Finds Hidden Liver Damage In Time For Treatment. Johns Hopkins oncologists find that tiny fragments of DNA circulating in the bloodstream may contain hidden clues. #MedicalResearch #HealthScience #Biotech #ScienceNews #PreventiveHealth
https://www.instagram.com/p/DW4P70ijd9M/
https://www.instagram.com/p/DW4P70ijd9M/
Howard G. Smith MD, AM on Instagram: "AI Blood Test Finds Hidden Liver Damage In Time For Treatment A new artificial-intelligence blood test, a higher tech liquid biopsy, may be able to detect silent liver disease years before symptoms appear. Oncologists at Johns Hopkins find that tiny fragments of DNA circulating in the bloodstream may contain hidden clues about early liver damage long before patients and their medical teams realize anything is wrong. The researchers analyzed blood samples from 1,576 people using an AI system that studies patterns in cell-free DNA fragments. Each test evaluated about 40 million DNA fragments spread across the genome. Instead of searching for specific gene mutations, the technology looks at how these fragments are broken apart and distributed. Such patterns help identify early liver fibrosis and cirrhosis, conditions that often go undetected with current screening tools. Liver disease affects an estimated 100 million Americans, and early stages are often silent without noticeable symptoms. Detecting liver scarring earlier could help doctors monitor patients and address underlying risk factors before serious complications and the need for a liver transplant develop. While this test is still experimental and not yet ready for routine use in clinical care, it highlights how AI-based blood analysis may help identify hidden disease earlier in the future. References on my website. #MedicalResearch #HealthScience #Biotech #ScienceNews #PreventiveHealth"
0 likes, 0 comments - drhowardsmithreports on April 8, 2026: "AI Blood Test Finds Hidden Liver Damage In Time For Treatment A new artificial-intelligence blood test, a higher tech liquid biopsy, may be able to detect silent liver disease years before symptoms appear. Oncologists at Johns Hopkins find that tiny fragments of DNA circulating in the bloodstream may contain hidden clues about early liver damage long before patients and their medical teams realize anything is wrong. The researchers analyzed blood samples from 1,576 people using an AI system that studies patterns in cell-free DNA fragments. Each test evaluated about 40 million DNA fragments spread across the genome. Instead of searching for specific gene mutations, the technology looks at how these fragments are broken apart and distributed. Such patterns help identify early liver fibrosis and cirrhosis, conditions that often go undetected with current screening tools. Liver disease affects an estimated 100 million Americans, and early stages are often silent without noticeable symptoms. Detecting liver scarring earlier could help doctors monitor patients and address underlying risk factors before serious complications and the need for a liver transplant develop. While this test is still experimental and not yet ready for routine use in clinical care, it highlights how AI-based blood analysis may help identify hidden disease earlier in the future. References on my website. #MedicalResearch #HealthScience #Biotech #ScienceNews #PreventiveHealth".